Atlas Trials

A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer

Clinical trial NCT07497919 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07497919
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Penile Cancer
Start date
2026-05-01
Primary completion
2029-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.